Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Julian Baker currently holds 46,480 shares of ALLOS THERAPEUTICS INC (ALTH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Julian Baker has been a net buyer of ALTH stock. They have purchased $681.1M and sold $115.7M worth of shares.
Julian Baker's most recent insider trade was on Oct 1, 2025, when they sold 50,640 shares at $1.38 per share.
Julian Baker serves as Executive at ALLOS THERAPEUTICS INC (ALTH). They have executed 1167 insider transactions totaling $796.7M over their tenure at the company.
Julian Baker holds the position of Executive at ALLOS THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Julian Baker has shown a buying trading pattern, with $681.1M in total purchases and $115.7M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Julian Baker was on May 29, 2024, when they purchased $336.0M worth of BCYC shares. This transaction involved 15,684,860 shares at $21.42 per share.
Julian Baker currently owns 46,480 shares of ALLOS THERAPEUTICS INC (ALTH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Julian Baker's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Julian Baker has 1167 Form 4 filings on record as an insider at ALLOS THERAPEUTICS INC.
Set alerts for Julian Baker and 40,000+ other insiders.